Ascendis Pharma A/S (BVMF:A1SN34)
70.21
0.00 (0.00%)
At close: Nov 4, 2025
Ascendis Pharma Revenue
Ascendis Pharma had revenue of 158.05M EUR in the quarter ending June 30, 2025, with 339.04% growth. This brings the company's revenue in the last twelve months to 490.75M, up 54.50% year-over-year. In the year 2024, Ascendis Pharma had annual revenue of 363.64M with 36.34% growth.
Revenue (ttm)
490.75M EUR
Revenue Growth
+54.50%
P/S Ratio
15.94
Revenue / Employee
482.54K EUR
Employees
1,017
Market Cap
64.46B BRL
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 363.64M | 96.92M | 36.34% |
| Dec 31, 2023 | 266.72M | 215.54M | 421.20% |
| Jan 1, 2023 | 51.17M | 43.40M | 557.93% |
| Dec 31, 2021 | 7.78M | 825.00K | 11.87% |
| Dec 31, 2020 | 6.95M | -6.42M | -48.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Empreendimentos Pague Menos | 14.27B |
| Diagnósticos da América | 13.93B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |
| Odontoprev | 2.53B |